Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Oct 31, 2022--
The "U.S. Real-World Evidence Solutions Market by Component, Application, End User - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The U.S. RWE solutions market is expected to grow at a CAGR of 13.1% from 2022 to 2029 to reach $2.22 billion by 2029
Growing incidence of chronic & infectious diseases, delays in drug development and the subsequent increase in development costs, rising focus towards personalized healthcare, a shift from volume to value-based care, and rapidly growing big data in healthcare are the key factors driving steady growth in the U.S. RWE solutions market.
Further, significant opportunities for existing market players and new entrants are provided by rising focus on end-to-end RWE services, and rising adoption of wearable devices and AI in RWE.
Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Key Market Trends
Scope of the Report
U.S. RWE Solutions Market, by Component
U.S. RWE Solutions Market, by Application
U.S. RWE Solutions Market, by End User
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Regulatory Analysis - U.S. Real-World Evidence (RWE) Solutions Market
6. Pricing Models (EMR/Genomic/Integrated Datasets)
7. U.S. Real-World Evidence Solutions Market, by Component
8. U.S. Real-World Evidence Solutions Market, by Application
9. U.S. Real-World Evidence Solutions Market, by End User
10. Competitive Landscape
11. Company Profiles (Business Overview, Financial Overview, Solution Portfolio, Strategic Developments)
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/wzw62r
View source version on businesswire.com:https://www.businesswire.com/news/home/20221031005489/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY INFECTIOUS DISEASES BIOMETRICS HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/31/2022 09:56 AM/DISC: 10/31/2022 09:56 AM
http://www.businesswire.com/news/home/20221031005489/en